CincyIP will be
holding its third CincyBIO conference on April 30, 2013 at the Phoenix in Cincinnati, OH. The conference will consist of the following
sessions:
• Exelixis and Novartis
-- Biopharm Patent Term Adjustment Based on (B) Delay;
• New FDA Regulations and Their Effect on Existing and Emerging
Technologies;
• Cintrifuse: Working with Technology Startups and Developing
Cincinnati's Innovation Ecosystem;
• University Intellectual Property: The Tech
Transfer Perspective;
• The Exhaustingly Self-Replicating Seeds: Monsanto
v. Bowman; and
• Gene: The New Four-Letter Word.
Additional information about the conference can be found here, and an agenda and list of speakers for the conference can be found here.
There registration fee for the conference is $125 (CincyIP member), $150 (non-member with CLE), $100 (non-member without CLE), or $25 (students). Those interested in registering can do so here.
Comments